Reports

NEWARK, N.J. – A Maryland man was sentenced today to 41 months in prison for illegally obtaining more than $2 million in COVID-19 relief funds.

Ocala, Florida – Senior United States District Judge Gregory A. Presnell has sentenced Passion Lajodia Jackson (31, Ocala) to two years in federal prison for wire fraud related to the Coronavirus Aid, Relief, and Economic Security (CARES) Act. As part of the judgment, Jackson was ordered to forfeit $20,132, which represents the proceeds obtained from the offense. Jackson had pleaded guilty on September 11, 2023.

SAN JUAN, P.R. – On December 13, 2023, the Federal Grand Jury in the District of Puerto Rico returned 11 separate indictments charging 11 individuals with the theft of federal-economic-impact payments from during the COVID-19 pandemic totaling $858,600, announced W. Stephen Muldrow, U.S. Attorney for the District of Puerto Rico. These cases were investigated by the Federal Bureau of Investigation (FBI), Puerto Rico Police Bureau (PRPB), and the Puerto Rico Department of Treasury (Hacienda).

Terence Aubrey Larker, 37, of Las Vegas, previously of Sacramento, was sentenced Tuesday to four years and 10 months in prison for mail fraud and aggravated identity theft in a scheme to defraud the Unemployment Insurance benefit program during the COVID-19 pandemic.

A Florida attorney has been convicted at trial for participating in a scheme to illegally obtain funding from a federal COVID-19 small business relief program.

Seattle - Paradise Williams, 29, the leader of a wide-ranging fraud scheme that stole more than $3.3 million from federally funded pandemic assistance programs and attempted to obtain more than $6.8 million, pleaded guilty today to wire fraud and money laundering charges, announced Acting U.S. Attorney Tessa M. Gorman.

A California man pleaded guilty yesterday to securities fraud, wire fraud, and obstruction of an official proceeding in connection with his scheme to defraud investors by making false and misleading statements about the purported development of a new, blood-based COVID-19 test, leading to millions of dollars in investor losses.